Zeb Younes

Chief Regulatory Officer, CMC

Therapeutic Areas

Drug	Indication	Phase
Investigational Gonadotropin	Assisted Reproductive Technology (ART)	Phase 3
AMH-targeted Therapies (via Oviva Therapeutics)	Reproductive Medicine	Preclinical or Early Clinical